| ID | Name | CAS | Data |
Inp |
| 50-303-9 |
1,3-Dimethyl-5-(3-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 2060.00 |
| 50-350-7 |
5-Ethyl-5-methyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 1340.00 |
| 50-502-8 |
3-[((1,1,3,3-Tetramethyl-3-[(3Z)-non-3-en-1-yloxy]disiloxanyl)oxy)methyl]pyridine
|
|
3 | 2149.80 |
| 50-651-3 |
benzaldehyde oxime, 2-hydroxy, 3-chloro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 2105.00 |
| 50-920-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 3161.00 |
| 51-206-6 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»,21-triol, MeTMS
|
|
3 | 2999.00 |
| 51-266-0 |
1-Methyl-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 1942.00 |
| 51-432-5 |
Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 3198.00 |
| 51-610-7 |
5-Cholesten-3-«beta»,7-«alpha»,25,26-tetrol, TMS
|
|
3 | 3630.00 |
| 51-692-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-pentyl-phosphorothioamidate
|
|
3 | 1581.00 |
| 52-092-2 |
2-Ethyl-5,5-dimethyl-5-propionyl-1,3,4-oxadiazoline
|
|
3 | 1240.00 |
| 52-103-9 |
N-(2-Furylmethyl)-N-tert-butyldimethylsilyl-9H-purin-6-amine
|
|
3 | 2592.00 |
| 52-132-7 |
Propanoic acid, 3-[N-(2-formyl-5-methyl-1-pyrrolyl)]
|
|
3 | 1568.00 |
| 52-331-6 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-toluol-), AC
|
|
3 | 2515.00 |
| 52-726-8 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 5-butyl-2,6-dimethyl
|
|
3 | 2160.00 |
| 52-806-9 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-alkyl-), AC
|
|
3 | 2425.00 |
| 53-012-9 |
Propanoic acid, 3-[N-(2-formyl-5-(hydroxymethyl)-1-pyrrolyl)]
|
|
3 | 1700.00 |
| 53-117-3 |
Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative
|
|
3 | [4282.00; 4363.00] |
| 53-684-4 |
5-«alpha»-Pregnan-3-«beta»-15x-diol-20-one, TMS
|
|
3 | 2856.00 |
| 53-798-8 |
Silane, dimethyldi(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
3 | 1105.00 |
| 53-802-2 |
Benzeneacetic acid, «alpha»-[[(trimethylsilyl)oxy]methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl ester, [7(S)-(1«alpha»,2«beta»,4«beta»,5«alpha»,7«beta»)]-
|
55373-83-6 |
3 | 2400.80 |
| 53-985-0 |
6-Chloro-N-sec-butyl-N'-heptafluorobutryl-1,3,5-triazine-2,4-diamine
|
|
3 | 1684.00 |
| 54-026-3 |
2,6-Pyridinedicarboxylic acid, ethyl 1-methoxydec-4-yl ester
|
|
3 | 2509.00 |
| 54-560-0 |
2,3,5,6,7,8,9,10-Octahydro-1H-cycloocta[d]pyrrolo[1,2-a]pyrimidin-11-one
|
|
3 | 2117.00 |
| 54-881-4 |
1,2,3,4,6,7,8,9,10,11-Decahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 2200.00 |
| 55-093-8 |
5-Ethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1050.00 |
| 55-267-5 |
2,3'-Bipyridine, 1'-acetyl-1',3,4,4',5,5',6,6'-octahydro-
|
|
3 | [1932.00; 1935.00] |
| 55-320-5 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-butyl-phosphorothioamidate
|
|
3 | 1530.00 |
| 55-407-9 |
2-Butenoic acid, 3-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
3 | [1261.00; 1282.00] |
| 55-533-9 |
1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
|
642-72-8 |
3 | [2350.00; 2414.00] |
| 55-599-7 |
2(1H)-Pyridinone, 3-acetyl-4-hydroxy-1,6-dimethyl-
|
7202-55-3 |
3 | 1672.00 |
| 55-862-4 |
5.beta.-Cholestane-3.alpha.,7.alpha.,26-triol, TMS
|
|
3 | 3526.00 |
| 56-086-5 |
2,3-Dihydro-1H-4,8a-diaza-cyclopenta[b]naphthalen-9-one
|
|
3 | 1968.00 |
| 56-112-5 |
5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 3196.00 |
| 56-323-1 |
N-(1,2-Dimethylpropyl)-N,N'-bis(trifluoroacetyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 1855.00 |
| 56-883-0 |
3-.beta.,7-.alpha.-Dihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
3 | [3181.00; 3182.00] |
| 57-058-5 |
3-[(Pyrrol1,1,3,3-tetramethyl-3-[(1-methylpentyl)oxy]disiloxanylmorphooxy)methyl]pyridine
|
|
3 | 1798.10 |
| 57-084-6 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, heptyl ester
|
|
3 | 2828.00 |
| 57-634-5 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, DMESI
|
|
3 | 3805.00 |
| 57-713-7 |
Trimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 1821.00 |
| 57-805-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6-methyl
|
|
3 | 1636.00 |
| 57-831-6 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, nonyl ester
|
|
3 | 2661.00 |
| 57-900-9 |
4-(tert-Butylamino)-6-ethyl-6-trifluoroacetylamino-5H-1,3,5-triazin-2-one
|
|
3 | 1116.00 |
| 57-905-4 |
Cholanic acid, 3«beta»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 3269.00 |
| 57-930-6 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopropyl-phosphorothioamidate
|
|
3 | 1420.00 |
| 58-050-2 |
3-oxy-7«alpha»-hydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
3 | 3535.00 |
| 58-110-5 |
5«beta»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | [2546.00; 2549.00] |
| 58-249-2 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 7-methyl
|
|
3 | 1998.00 |
| 58-457-1 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-propyl-phosphorothioamidate
|
|
3 | 1387.00 |
| 58-480-5 |
5-«alpha»-Androstan-3-«beta»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 2720.00 |
| 58-508-4 |
3,17-Bis[(trimethylsilyl)oxy]-5«beta»-androstane, (3«beta»,17«beta»)-
|
18880-48-3 |
3 | [2545.00; 2571.00] |
| 58-624-5 |
2,6-Pyridinedicarboxylic acid, di(2,4,4-trimethylpentyl) ester
|
|
3 | 2529.00 |
| 58-638-0 |
2,5-Diethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1200.00 |
| 58-811-7 |
24-Nor-5.beta.-cholestane-3.alpha.,7.alpha.,25-triol, TMS
|
|
3 | 3339.00 |
| 58-886-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 8-methyl
|
|
3 | 1638.00 |
| 59-007-9 |
4H-Cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 9-methyl
|
|
3 | 2023.00 |
| 59-082-6 |
5-Pregnen-3«beta»,17«alpha»,20«alpha»-triol, (VDMS)2
|
|
3 | 3238.00 |
| 59-134-8 |
5-Androstene-3-«beta»,15-«alpha»,16-«alpha»,17-«beta»-tetrol, TMS
|
|
3 | 3035.00 |
| 59-367-0 |
Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 3628.00 |
| 59-804-4 |
benzaldehyde oxime, 2-hydroxy, 3-nitro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 2241.00 |
| 59-894-5 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 4-octyl ester
|
|
3 | 2391.00 |
| 59-897-2 |
5,5-Diethyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 1410.00 |
| 60-181-4 |
1H-1,2,4-Triazole, 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]-
|
112281-77-3 |
3 | [1998.00; 2013.00] |
| 60-576-6 |
L-Tryptophan, N(O,S)-ethoxycarbonyl, (S)-(+)-3-methyl-2-butyl ester
|
|
3 | 2664.80 |
| 60-608-0 |
2-Octalen-1-one, 3,4a,8,8-tetramethyl, 4-(2-(3-furyl)ethyl))
|
|
3 | 2089.00 |
| 60-814-1 |
[(1R,8R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] (E)-4-hydroxy-3-methyl-but-2-enoate
|
|
3 | 2110.00 |
| 60-877-2 |
5-Ethyl-2,5-dimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 1110.00 |
| 60-925-8 |
2,6-Pyridinedicarboxylic acid, 5-methoxy-3-methylpent-2-yl propyl ester
|
|
3 | 2239.00 |
| 60-927-6 |
Pyrrolidino[1,2-e]-4H-1,3,5-dithiazine, 4-methyl-2-(2-methylpropyl)
|
|
3 | 1703.00 |
| 60-952-8 |
1-[3,4-methylenedioxy-benzyl]piperazine -M, (desmethylen-methyl-), 2AC
|
|
3 | 2380.00 |
| 61-249-8 |
5H-Dibenz[c,e]azepine, 6,7-dihydro-6-(2-propenyl)-
|
146-36-1 |
3 | [1917.00; 1975.00] |
| 61-408-1 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, propyl ester
|
|
3 | 2396.00 |
| 61-543-1 |
Ergostanol (24«alpha»-methyl-5«alpha»-cholestan-3«beta»-ol), TMS
|
|
3 | 3216.00 |
| 61-842-9 |
5-Ethyl-5-methyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 1130.00 |
| 61-932-9 |
«alpha»-D-Glucopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
3327-61-5 |
3 | 1924.00 |
| 62-108-3 |
3-«alpha»,6-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
3 | [3428.00; 3483.00] |
| 62-117-3 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-bis-(2-propenyl), 1,3-bis-(chloromethyl)
|
|
3 | 1680.00 |
| 62-379-3 |
N-tert-Butyl-N-trifluoroacetyl-N'-trifluoroacetyl-N'-cyclopropyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 1882.00 |
| 62-390-0 |
7H-Furo[3,2-g][1]benzopyran-7-one, 2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (S)-
|
13849-08-6 |
3 | 2322.00 |
| 62-401-7 |
5-[2-(4-Allyl-2,6-dimethoxy-phenoxy)-1-hydroxy-propyl]-2-methoxy-phenol, TES
|
|
3 | 3310.00 |
| 62-445-9 |
O-(2-Chloroethyl)-O-(1,1-difluoro-2-chloroethyl)-phosphorothiochloridate
|
|
3 | 1362.00 |
| 62-451-2 |
6,7,8,9,10,11-Hexahydro-5,11a-diaza -cycloocta[b]naphthalen-12-one
|
|
3 | 2181.00 |
| 62-526-9 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 2-methyl
|
|
3 | 1657.00 |
| 62-967-0 |
2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | [1958.00; 1973.00] |
| 63-024-5 |
Phosphorothioic acid, O-(6-ethoxy-2-ethyl-4-pyrimidinyl) O,O-dimethyl ester
|
38260-54-7 |
3 | [1780.00; 1824.00] |
| 63-461-0 |
Benzofuran-2,3-dione, 2-[O-(2-acetoxyethyl)oxime], 3-(O-methyloxime), isomer 1
|
|
3 | 2097.00 |
| 63-513-2 |
5«alpha»-Androstane-2«beta»,3«beta»,17«beta»-triol, TMS
|
|
3 | 2869.00 |
| 63-550-1 |
[7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] 1H-pyrrole-3-carboxylate
|
|
3 | 2088.00 |
| 64-017-2 |
10-Methyl-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-12-one
|
|
3 | 2123.00 |
| 64-078-5 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, tridecyl ester
|
|
3 | 3067.00 |
| 64-153-1 |
4,8-Secosenecionan-8,11,16-trione, 15,20-dihydro-12-(acetyloxy)-20-chloro-15-hydroxy-4-methyl-
|
60367-00-2 |
3 | 2849.00 |
| 64-263-9 |
1«beta»,2«beta»-Epoxy-7-hydroxy-1«alpha»-methoxymethyl-8«alpha»-pyrrolizidine
|
|
3 | 1460.00 |
| 64-652-7 |
N-tert-Butyl-6-methoxy-1,3,5-triazine-2,4-diamine
|
30125-64-5 |
3 | 1726.00 |
| 64-675-2 |
(24S)-24-ethyl-5«alpha»-cholestan-3«beta»,24-diol, TMS
|
|
3 | [3572.00; 3574.00] |
| 64-888-6 |
5-(4-Chlorophenyl)-6-ethylpyrimidine-2,4-diamine, N,N'-bis(pentafluoropropionyl)-
|
|
3 | 2072.00 |
| 64-991-1 |
5-«beta»-Androstan-3-«alpha»-ol-17-«beta»-carboxylate, MeTMS
|
|
3 | 2659.00 |
| 65-071-1 |
6-isopropyl-4-methyl-7,8-dihydro-6H-naphtho[1,8-bc]furan (acorafuran)
|
|
3 | 1735.00 |
| 65-189-1 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 2123.00 |
| 65-194-5 |
2H-Pyrido[2,1-b]quinazolin-6-one, 1,3,4,6,7,8,9,10-octahydro-7-methyl
|
|
3 | 2045.00 |
| 65-262-9 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl
|
|
3 | 1600.00 |
|
« Previous Results
Next Results »
|